| Victoria Sydeco Tayengco-maisog, MD | |
|
9304 Trieste Drive, Fort Myers, FL 33913 | |
| (239) 707-4155 | |
| (239) 415-0028 |
| Full Name | Victoria Sydeco Tayengco-maisog |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 9304 Trieste Drive, Fort Myers, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144572249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME103467 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Victoria Sydeco Tayengco-maisog, MD 9304 Trieste Drive, Fort Myers, FL 33913 Ph: (239) 707-4155 | Victoria Sydeco Tayengco-maisog, MD 9304 Trieste Drive, Fort Myers, FL 33913 Ph: (239) 707-4155 |
News Archive
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
Researchers from the Institute of Psychiatry at King's College London have identified a molecule that could be targeted to treat the cognitive impairment in people with Down syndrome.
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.
› Verified 8 days ago
Price S Ward, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9981 S Healthpark Dr, Fort Myers, FL 33908 Phone: 239-343-5000 | |
Melanie Aliza Coombs-bynum, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9350 Camelot Dr, Fort Myers, FL 33919 Phone: 239-481-5437 Fax: 239-481-0570 | |
Dr. Emad S Mansour, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9981 S Healthpark Dr, Fort Myers, FL 33908 Phone: 239-343-5651 Fax: 239-343-5652 | |
Cayce Jehaimi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15901 Bass Rd Ste 102, Fort Myers, FL 33908 Phone: 239-343-9890 Fax: 239-343-9898 | |
Dr. Dana Debord Crater, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9350 Camelot Dr, Fort Myers, FL 33919 Phone: 239-481-5437 Fax: 239-481-0570 | |
Dr. Robert Edward Rayder, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4048 Evans Ave Ste 209, Fort Myers, FL 33901 Phone: 239-278-9983 Fax: 239-278-9985 | |
Dr. Hetty Zoe Snyderman, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 21 Carrotwood Ct, Fort Myers, FL 33919 Phone: 239-898-8988 |